Exemestane versus anastrozole in postmenopausal women with early breast cancer: NCIC CTG MA.27 - A randomized controlled phase III trial

Paul E. Goss, James N. Ingle, Kathleen I. Pritchard, Matthew J. Ellis, George W. Sledge, G. Thomas Budd, Manuela Rabaglio, Rafat H. Ansari, David B. Johnson, Richard Tozer, David P. D'Souza, Haji Chalchal, Silvana Spadafora, Vered Stearns, Edith A. Perez, Pedro E.R. Liedke, Istvan Lang, Catherine Elliott, Karen A. Gelmon, Judy Anne W. ChapmanLois E. Shepherd

Research output: Contribution to journal › Article › peer-review

163 Scopus citations

Fingerprint

Dive into the research topics of 'Exemestane versus anastrozole in postmenopausal women with early breast cancer: NCIC CTG MA.27 - A randomized controlled phase III trial'. Together they form a unique fingerprint.

Medicine & Life Sciences